OTC Drugs Market Scope, Report & Analysis

1
Global OTC Drugs Market to Expand from 2023-2035
at a CAGR of 7 Says Kenneth Research
Worldwide Practice of Self Medication and the
Seasonal Recurring of Influenza to Drive the
Growth Kenneth Research published a report titled
OTC Drugs Market Global Demand Analysis
Opportunity Outlook 2035 which delivers detailed
overview of the global OTC drugs market in terms
of market segmentation by product type, dosage
form, route of administration, distribution
channel, and by region. Further, for the in-depth
analysis, the report encompasses the industry
growth indicators, restraints, supply and demand
risk, along with detailed discussion on current
and future market trends that are associated with
the growth of the market.
Kenneth Research projects the global OTC drugs
market to witness growth from USD 151 billion
in 2022 to USD 294 billion in 2035. The market
growth is expected to occur as a result of
several factors, including self-medication for
treating specific symptoms, the recurrence of
seasonal influenza, the cost-effectiveness of
over-the-counter (OTC) drugs, the geriatric
population, and the growth of online pharmacies.
2
Further, the global OTC drugs market is projected
to grow at a CAGR of 7 during the forecast
period. The market is segmented by route of
application into oral, parental, topical, and
others. Of these, the orally administrated
segment is anticipated to hold the largest
market share by the end of 2035, owing to its
safety, convenience, and cost-
effectiveness. For more informations_at_https//www.
kennethresearch.com/report-details/otc-drugs-
market-/10352513 The regional markets of North
America, Europe, Asia Pacific, Latin America, the
Middle East, and Africa constitute the global
OTC drugs market. Of these, the market in the
European region is expected to show the most
significant growth for the spike in the sales of
OTC drugs, awareness about the usage of OTC
drugs, and the evolution of online
pharmacies. The research is global in nature and
covers detailed analysis on the market in North
America (U.S., Canada), Europe (U.K., Germany,
France, Italy, Spain, Hungary, Belgium,
Netherlands Luxembourg, NORDIC Finland,
Sweden, Norway, Denmark, Poland, Turkey,
Russia, Rest of Europe), Latin America (Brazil,
Mexico, Argentina, Rest of Latin America),
Asia-Pacific (China, India, Japan, South Korea,
Indonesia, Singapore, Malaysia, Australia, New
Zealand, Rest of Asia-Pacific), Middle East and
Africa (Israel, GCC Saudi Arabia, UAE, Bahrain,
Kuwait, Qatar, Oman, North Africa, South Africa,
Rest of Middle East and Africa). In addition,
analysis comprising market size, Y-O-Y growth
opportunity analysis, market players competitive
study, investment opportunities, demand for
future outlook etc. has also been covered and
displayed in the research report. Recurrence of
Seasonal Influenza to Encourage the Market
Growth Influenza has been observed to cause up to
5 million cases of grave illness and up to
650001 respiratory deaths every year. Influenza
usually occurs in the winter or places of low
temperature. Then the dehydration of the mucus
membrane due to the cold makes it easier for
respiratory
3
viruses to enter the body. This leads to
widespread viral influenza accompanied by
several symptoms, such as headache, chills,
cough, runny nose, and more. Many of these
symptoms could be self-diagnosed and treated
effectively with OTC medicines, thus boosting
market growth. However, strict regulations of the
government, reactions of OTC medicines with other
medicines, and people with specific medical
conditions operate as key restraints to the
growth of the global OTC drugs market over the
forecast period. This report also provides the
existing competitive scenario of some of the key
players of the global OTC drugs market which
includes company profiling of Bayer AG, Takeda
Pharmaceutical Company Limited, Pfizer Inc.,
Johnson Johnson Services, Inc., Sanofi US,
Reckitt Benckiser Group PLC, Novartis AG,
Boehringer Ingelheim International GmbH.,
GlaxoSmithKline plc., Glenmark Pharmaceuticals
Limited, and others. The profiling enfolds key
information of the companies which encompasses
business overview, products and services, key
financials and recent news and developments. On
the whole, the report depicts detailed overview
of the global OTC drugs market that will help
industry consultants, equipment manufacturers,
existing players searching for expansion
opportunities, new players searching
possibilities and other stakeholders to align
their market centric strategies according to the
ongoing and expected trends in the
future. Request Report Sample_at_ https//www.kenneth
research.com/sample-request- 10352513 Kenneth
Research is a leading service provider for
strategic market research and consulting. We aim
to provide unbiased, unparalleled market insights
and industry analysis to help industries,
conglomerates and executives to take wise
decisions for their future marketing strategy,
expansion and investment etc. We believe every
business can expand to its new horizon, provided
a right guidance at a right time is available
through strategic minds. Our out of box thinking
helps our clients to take wise decision in order
to avoid future uncertainties.
4
Contact for more Info AJ Daniel Email
sales_at_kennethresearch.com U.S. Phone [phone]
0609